id: pea_administration_to_th1_cell_differentiation
name: Palmitoylethanolamide (PEA) Administration â†’ Type 1 T Helper (Th1) Cell Differentiation
from_node:
  node_id: pea_administration
  node_name: Palmitoylethanolamide (PEA) Administration
to_node:
  node_id: th1_cell_differentiation
  node_name: Type 1 T Helper (Th1) Cell Differentiation
direction: negative
category: biological
mechanism_pathway:
- 'Step 1: PEA lipid mediator is administered as a therapeutic intervention'
- 'Step 2: PEA inhibits expression of master transcription factors crucial for Th1
  cell differentiation'
- 'Step 3: Reduced transcription factor expression suppresses Th1 cell development'
- 'Step 4: Decreased Th1 cells reduces pathogenic T cell responses associated with
  autoimmune diseases'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Yasuhiro Soga et al. 2025. "Lipid mediator palmitoylethanolamide
    (PEA) inhibits pathogenic T cell differentiation in vitro and in vivo.." *Biochemical
    and biophysical research communications*. https://doi.org/10.1016/j.bbrc.2024.151085
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.110198'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/biological/pea_administration_to_th1_cell_differentiation.yaml
_category: biological
